These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J. J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944 [Abstract] [Full Text] [Related]
3. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. Weiss HJ, Sussman II, Hoyer LW. J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621 [Abstract] [Full Text] [Related]
4. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. Weiss HJ, Rogers J, Brand H. J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262 [Abstract] [Full Text] [Related]
7. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas. Bennett B, Forman WB, Ratnoff OD. J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413 [Abstract] [Full Text] [Related]
11. Hemophilia and von Willebrand's disease: genetic considerations. Green D. Ann Clin Lab Sci; 1980 Sep; 10(2):123-7. PubMed ID: 6770741 [Abstract] [Full Text] [Related]
13. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test). McPherson J, Soberano ME, Macdonald C, Zucker MB. Thromb Haemost; 1984 Apr 30; 51(2):272-4. PubMed ID: 6429885 [Abstract] [Full Text] [Related]
14. Open-heart surgery in von Willebrand's disease. Aris A, Pisciotta AV, Hussey CV, Gale H, Lepley D. J Thorac Cardiovasc Surg; 1975 Feb 30; 69(2):183-7. PubMed ID: 1078707 [Abstract] [Full Text] [Related]
15. Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor. Zimmerman TS, Ratnoff OD, Powell AE. J Clin Invest; 1971 Jan 30; 50(1):244-54. PubMed ID: 5543879 [Abstract] [Full Text] [Related]
16. [Biological half-time of factor VIII antigen (antihemophilic globulin) in hemophilia A and in von Willebrand's disease]. Uszyński L. Acta Haematol Pol; 1974 Jan 30; 5(3):189-94. PubMed ID: 4546992 [No Abstract] [Full Text] [Related]
17. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease. McCarroll DR, Ruggeri ZM, Montgomery RR. J Lab Clin Med; 1984 May 30; 103(5):704-11. PubMed ID: 6609219 [Abstract] [Full Text] [Related]
18. Treatment of von Willebrand's disease. Mannucci PM. J Intern Med Suppl; 1997 May 30; 740():129-32. PubMed ID: 9350194 [Abstract] [Full Text] [Related]
19. [Radioimmunoassay of antihemophilic factor A]. Strike L, Saint Paul B, Chassaigne M, Allain JP. Nouv Presse Med; 1976 Dec 11; 5(42):2877-9. PubMed ID: 1087007 [Abstract] [Full Text] [Related]
20. A bleeding disease (von Willebrand's disease) in a Chesapeake Bay Retriever. Johnson GS, Lees GE, Benson RE, Rosborough TK, Dodds WJ. J Am Vet Med Assoc; 1980 Jun 01; 176(11):1261-3. PubMed ID: 6776082 [Abstract] [Full Text] [Related] Page: [Next] [New Search]